MedTrace Logo

Intraoperative Imaging With ICG Registry

NCT02640170 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 291

Last updated 2021-06-24

No results posted yet for this study

Summary

The purpose of this registry is to monitor the rate of recurrence in patients who undergo cancer surgery.

Conditions

  • Lung Nodule, Breast, Kidney,Parathyroid, Mediastinal, Skin Mass, Soft Tissue, Prostate, Stomach Pleural, Head and Neck, and Are at Risk of Recurrence

Interventions

OTHER

Registry

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Sunil Singhal, MD, PhD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02640170 on ClinicalTrials.gov